About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Jan 21, 2020...
A new computer algorithm developed by researchers at the Weizmann Institute of Science in Rehovot can predict which women are at a high risk of gestational diabetes in the early stages of pregnancy or even before it has occurred, the institute said in a press release Monday afternoon.
The study analyzed data on nearly 600,000 pregnancies available from Israel's largest health insurance provider, Clalit Health Services, the Weizmann Institute of Science said. According to the institute, the algorithm may help prevent gestational diabetes using nutritional and lifestyle changes.
Jan 21, 2020...
Non-communicable diseases including heart disease, cancer and lung disease are now the most common causes of death, accounting for 70 percent of deaths worldwide. These diseases are considered “non-communicable” because they are thought to be caused by a combination of genetic, lifestyle and environmental factors and can't be transmitted between people.
A new research paper in Science by a team of fellows in CIFAR's Humans and the Microbiome program throws this long-held belief into question by providing evidence that many diseases may be transmissible between people through microbes (including bacteria, fungi, and viruses) that live in and on our bodies.
https://www.weizmann-usa.org/news-media/news-releases/new-algorithm-predicts-gestational-diabetes/
Jan 13, 2020... REHOVOT, ISRAEL—January 13, 2020—A new computer algorithm enables prediction, in the early stages of pregnancy or even before pregnancy has occurred, of which women are at a high risk of gestational diabetes. Conducted by researchers at the Weizmann Institute of Science, the study was reported in Nature Medicine. The scientists analyzed data on nearly 600,000 pregnancies available from Israel’s largest health organization, Clalit Health Services. It may be possible, based on these predictions, to prevent gestational diabetes using nutritional and lifestyle changes.
Dec 09, 2021... REHOVOT, ISRAEL—December 9, 2021—An exclusive “license” for making insulin in the human body belongs to the beta cells scattered throughout the pancreas. But because beta cells can become scarce or dysfunctional in people with diabetes, scientists have been searching for other cells that might be coaxed into manufacturing the vital glucose-regulating hormone. In a study published today in Nature Medicine, researchers from the Weizmann Institute of Science and from Yale School of Medicine discovered insulin-making cells in an unexpected place, the fetal intestine. This discovery may open up new directions in the future development of potential treatments for diabetes.
©2022 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR